| 1 |
World Health Organization (WHO). Global tuberculosis report 2015[EB/OL]. Geneva,2015.
URL
|
| 2 |
World Health Organization (WHO). Guidelines on the management of latent tuberculosis infection[EB/OL]. Geneva, 2015.
URL
|
| 3 |
中华医学会结核病学分会. γ-干扰素释放试验在中国应用的建议[J]. 中华结核和呼吸杂志,2014,37(10):744-747.
|
| 4 |
Pai M, Zwerling A, Menzies D, et al. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update[J]. Ann Intern Med,2008,149(3):177-184.
|
| 5 |
Scholman T, Straub M, Sotgiu G, et al. Superior sensitivity of ex vivo IFN-γ release assays as compared to skin testing in immunocompromised patients[J]. Am J Transplant,2015,15(10):2616-2624.
|
| 6 |
Markowitz N, Hansen NI, Wilcosky TC, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group[J]. Ann Intern Med,1993,119(3):185-193.
|
| 7 |
Fisk TL, Hon HM, Lennox JL, et al. Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy[J]. AIDS,2003,17(7):1102-1104.
|
| 8 |
Stephan C, Wolf T, Goetsch U, et al. Comparing QuantiFERON-tuberculosis Gold, T-SPOT tuberculosis and tuberculin skin test in HIV-infected individuals from a low prevalence tuberculosis country[J]. AIDS,2008,22(18):2471-2479.
|
| 9 |
Elzi L, Steffen I, Furrer H, et al. Improved sensitivity of an interferon-release assay (T-SPOT.TB™) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection[J]. BMC Infect Dis,2011,11:319.
|
| 10 |
Santin M, Casas S, Saumoy M, et al. Detection of latent tuberculosis by the tuberculin skin test and a whole-blood interferon-release assay, and the development of active tuberculosis in HIV-seropositive persons[J]. Diagn Microbiol Infect Dis,2011,69(1):59-65.
|
| 11 |
Talati NJ, Gonzalez-Diaz E, Mutemba C, et al. Diagnosis of latent tuberculosis infection among HIV discordant partners using interferon release assays[J]. BMC Infect Dis,2011,11:264.
|
| 12 |
Komiya K, Ariga H, Nagai H, et al. Impact of peripheral lymphocyte count on the sensitivity of 2 IFN-gamma release assays, QFT-G and ELISPOT, in patients with pulmonary tuberculosis[J]. Inter Med,2010,49(17):1849-1855.
|
| 13 |
Cattamanchi A, Smith R, Steingart KR, et al. Interferon-release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis[J]. J Acquir Immune Defic Syndr,2011,56(3):230-238.
|
| 14 |
Redelman-Sidi G, Sepkowitz KA. IFN-γ release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults[J]. Am J Respir Crit Care Med,2013,188(4):422-431.
|
| 15 |
Melath S, Ismajli M, Smith R, et al. Screening for latent TB in patients with rheumatic disorders prior to biologic agents in a 'high-risk’ TB population: comparison of two interferon gamma release assays[J]. Rheumatol Int,2014,34(1):149-150.
|
| 16 |
Singanayagam A, Manalan K, Sridhar S, et al. Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-α antagonist therapy[J]. Thorax,2013,68(10):955-961.
|
| 17 |
Vassilopoulos D, Tsikrika S, Hatzara C, et al. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy[J]. Clin Vaccine Immunol,2011,18(12):2102-2108.
|
| 18 |
Wong SH, Gao Q, Tsoi KK, et al. Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis[J]. Thorax,2016,71(1):64-72.
|
| 19 |
Mazurek GH, Jereb J, Lobue P, et al. Guidelines for using the QuantiFERON-TB gold test for detecting Mycobacterium tuberculosis infection[J]. MM-WR Recomm Rep,2005,54(RR-15):49-55.
|
| 20 |
Kim KH, Lee SW, Chung WT, et al. Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents[J]. Korean J Lab Med,2011,31(4):271-278.
|
| 21 |
Park JH, Seo GY, Lee JS, et al. Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial[J]. J Rheumatol,2009,36(10):2158-2163.
|
| 22 |
Jung HJ, Kim TJ, Kim HS, et al. Analysis of predictors influencing indeterminate whole blood interferon gamma release assay results in patients with rheumatic diseases[J]. Rheumatol Int,2014,34(12):1711-1720.
|
| 23 |
Wong SH, Ip M, Tang W, et al. Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients[J]. Inflamm Bowel Dis,2014,20(11):2067-2072.
|
| 24 |
Rodriguez GH, Safdar A. Impact of cytotoxic and targeted antineoplastic drugs on the validity of the mitogen-induced interferon-gamma release assay for latent tuberculosis infection: results of a prospective trial at a comprehensive cancer center[J]. Scand J Infect Dis,2014,46(1):52-57.
|
| 25 |
Walsh MC, Camerlin AJ, Miles R, et al. The sensitivity of interferon-gamma release assays is not compromised in tuberculosis patients with diabetes[J]. Int J Tuberc Lung Dis,2011,15(2):179-184.
|
| 26 |
Chen J, Sun J, Zhang R, et al. T-SPOT.TB in the diagnosis of active tuberculosis among HIV-infected patients with advanced immunodeficiency[J]. AIDS Res Hum Retroviruses,2011,27(3):289-294.
|
| 27 |
SantinM, Munoz L, Rigau D. Interferon-release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis[J]. PLoS One,2012,7:e32482.
|
| 28 |
Use of interferon-gamma release assays in support of TB diagnosis. European Centre for Disease Prevention and Control (ECDC) [EB/OL]. Stockholm, March 2011. Available from:
URL
|
| 29 |
Denkinger CM, Dheda K, PaiM. Guidelines on interferon-release assays for tuberculosis infection: concordance, discordance or confusion?[J]. Clin Microbiol Infect,2011,17(6):806-814.
|
| 30 |
钟一鸣，谷秀梅，刘文恩, 等. 结核感染T细胞斑点实验在结缔组织病患者中辅助诊断结核感染的应用[J]. 中华检验医学杂志,2014,37(2):132-135.
|
| 31 |
International Union against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial[J]. Bull World Health Organ,1982,60(4):555-564.
|
| 32 |
Bush OB Jr, Sugimoto M, Fujii Y, et al. Isoniazid prophylaxis in contacts of persons with known tuberculosis: second report[J]. Am Rev Respir Dis,1965,92(5):732-740.
|